BridgeBio Pharma News

BridgeBio Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.8%)

Oct 22 18:11 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner KKR Genetic Disorder L.P.

Sep 17 18:50 ET

BridgeBio Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KKR Genetic Disorder L.P.(13.4%),KKR Genetic Disorder GP LLC(13.4%), etc.

Sep 17 18:45 ET

BridgeBio Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(13.4%),O. Andreas Halvorsen(13.4%), etc.

Aug 20 20:43 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil

Aug 20 18:33 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C

Aug 20 18:29 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Trimarchi Thomas

Aug 20 18:28 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Trimarchi Thomas

Aug 8 16:46 ET

BridgeBio Pharma | 3: Initial statement of beneficial ownership of securities-Officer Trimarchi Thomas

Jul 29 20:20 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Valantine Hannah

Jun 25 17:46 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Scott Randal W.

Jun 25 17:46 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Satvat Ali J.

Jun 25 17:46 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director MOMTAZEE JAMES C

Jun 25 17:41 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Hassan Fred

Jun 25 17:41 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Ellis Andrea

Jun 25 17:41 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director MCCORMICK FRANK

Jun 25 17:41 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Lo Andrew

Jun 25 17:41 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director HOMCY CHARLES J

Jun 25 17:41 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director DANIELS RONALD J

Jun 25 17:41 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Dachille Douglas A.

Jun 25 17:41 ET